Tarveda Therapeutics
Tarveda Therapeutics develops miniature drug conjugates that target solid tumors by delivering cytotoxic agents directly to cancer cells, minimizing damage to healthy tissue. This approach aims to improve treatment efficacy and reduce side effects for patients with various types of solid tumors.
- Biotechnology
Updated 7 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Tarveda Therapeutics develops miniature drug conjugates that target solid tumors by delivering cytotoxic agents directly to cancer cells, minimizing damage to healthy tissue. This approach aims to improve treatment efficacy and reduce side effects for patients with various types of solid tumors.